Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency

Ann Hum Genet. 1975 Jan;38(3):327-31. doi: 10.1111/j.1469-1809.1975.tb00617.x.

Abstract

Since 1967 a syndrome characterized by renal disease, normochromic anaemia and corneal opacities has been described in 7 members of 3 different Norweigan families. The patients have low levels of esterified cholesterol and lack LCAT (lecithin: cholesterol acyltransferase) activity in plasma. The genetic basis of the disorder seems to be the presence of a LCAT deficiency gene in double dose. This gene is probably the result of a single mutational event. Linkage studies revealed non-random assortment between LCTA deficiency and serum haptoglobin (Hp) types. After Hp subtyping a combined lod score of 3-41 at a recombination fraction of 0-00 was obtained. Association was revealed between the LCAT deficiency gene and the Hp-1S gene. We propose that the LCAT gene is situated close to the alpha-haptoglobin locus on chromosome no. 16.

MeSH terms

  • Acyltransferases / deficiency*
  • Anemia / etiology
  • Chromosome Aberrations
  • Chromosome Disorders
  • Chromosomes, Human, 16-18
  • Corneal Opacity / etiology
  • Female
  • Genetic Linkage
  • Haptoglobins / analysis
  • Humans
  • Kidney Diseases / etiology
  • Lecithin Cholesterol Acyltransferase Deficiency*
  • Lipid Metabolism, Inborn Errors / enzymology
  • Male
  • Molecular Biology
  • Mutation
  • Pedigree
  • Phosphatidylcholine-Sterol O-Acyltransferase / blood
  • Probability
  • Recombination, Genetic
  • Syndrome

Substances

  • Haptoglobins
  • Acyltransferases
  • Phosphatidylcholine-Sterol O-Acyltransferase